Guzman y Gomez shares soar more than 39% on trading debut
An exterior view of the Guzman Y Gomez Mexican Kitchen on June 13, 2024 in Port Macquarie, Australia. James D. Morgan | Getty Images News | Getty Images Mexican-themed fast-food …
An exterior view of the Guzman Y Gomez Mexican Kitchen on June 13, 2024 in Port Macquarie, Australia. James D. Morgan | Getty Images News | Getty Images Mexican-themed fast-food …
An employee adjusts a sneaker display inside a Golden Goose SpA store in the Mayfair district of London, UK, on Monday, Dec. 4, 2023. Roughly a dozen banks competed for …
Chinese ride-hailing giant Didi Chuxing, whose New York initial public offering (IPO) in 2021 triggered a cybersecurity investigation by mainland authorities that led to its delisting and a $1.2 billion …
Initial public offering (IPO) activity in Hong Kong is gearing up for a busier second half of the year, shaking off a slow first six months as more Chinese companies …
According to multiple people who worked with Xu, the Chinese billionaire has decided to stay away from the limelight because of his personality and the belief that any attention drawn …
Hong Kong’s capital market, which had wallowed in a bear market for three years during the Covid-19 pandemic, has picked up since Chan’s appointment. The city’s benchmark Hang Seng Index …
QuantumPharm’s shares soared on their trading debut in Hong Kong, as traders piled into the stock even before the AI-powered pharmaceuticals researcher posted any profit. Listed under the stock code …
NIP is a Cayman Islands-based holding company, with operations primarily conducted through two wholly-owned subsidiaries: Ninjas in Pyjamas Gaming in Sweden, which is engaged in esports teams operations; and Wuhan …
Tempus, a genomic testing and data analysis company started by Eric Lefkosky, who previously founded Groupon, debuted on Nasdaq on Friday, rose about 15% on the opening. The company priced …
Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in …